These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 25315410

  • 1. A novel antibiotic-delivery system by using ovotransferrin as targeting molecule.
    Ibrahim HR, Tatsumoto S, Ono H, Van Immerseel F, Raspoet R, Miyata T.
    Eur J Pharm Sci; 2015 Jan 23; 66():59-69. PubMed ID: 25315410
    [Abstract] [Full Text] [Related]

  • 2. Potent antimicrobial action of triclosan-lysozyme complex against skin pathogens mediated through drug-targeted delivery mechanism.
    Hoq MI, Ibrahim HR.
    Eur J Pharm Sci; 2011 Jan 18; 42(1-2):130-7. PubMed ID: 21078387
    [Abstract] [Full Text] [Related]

  • 3. Triclosan-lysozyme complex as novel antimicrobial macromolecule: a new potential of lysozyme as phenolic drug-targeting molecule.
    Hoq MI, Mitsuno K, Tsujino Y, Aoki T, Ibrahim HR.
    Int J Biol Macromol; 2008 Jun 01; 42(5):468-77. PubMed ID: 18439671
    [Abstract] [Full Text] [Related]

  • 4. Novel anticancer activity of the autocleaved ovotransferrin against human colon and breast cancer cells.
    Ibrahim HR, Kiyono T.
    J Agric Food Chem; 2009 Dec 09; 57(23):11383-90. PubMed ID: 19886663
    [Abstract] [Full Text] [Related]

  • 5. Antifungal activity of ovotransferrin towards genus Candida.
    Valenti P, Visca P, Antonini G, Orsi N.
    Mycopathologia; 1985 Mar 09; 89(3):169-75. PubMed ID: 2985999
    [Abstract] [Full Text] [Related]

  • 6. Identification of a distinct antibacterial domain within the N-lobe of ovotransferrin.
    Ibrahim HR, Iwamori E, Sugimoto Y, Aoki T.
    Biochim Biophys Acta; 1998 Mar 05; 1401(3):289-303. PubMed ID: 9540819
    [Abstract] [Full Text] [Related]

  • 7. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M.
    Expert Rev Anti Infect Ther; 2011 Nov 05; 9(11):1035-52. PubMed ID: 22029522
    [Abstract] [Full Text] [Related]

  • 8. Modulation of Formation, Physicochemical Properties, and Digestion of Ovotransferrin Nanofibrils with Covalent or Non-Covalent Bound Gallic Acid.
    Wei Z, Huang Q.
    J Agric Food Chem; 2019 Sep 04; 67(35):9907-9915. PubMed ID: 31436102
    [Abstract] [Full Text] [Related]

  • 9. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P, Allison DG, McBain AJ.
    Symp Ser Soc Appl Microbiol; 2002 Sep 04; (31):98S-110S. PubMed ID: 12481835
    [Abstract] [Full Text] [Related]

  • 10. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P, Allison DG, McBain AJ.
    J Appl Microbiol; 2002 Sep 04; 92 Suppl():98S-110S. PubMed ID: 12000619
    [Abstract] [Full Text] [Related]

  • 11. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP, DiTullio P, Parkinson S.
    Future Microbiol; 2015 Sep 04; 10(11):1751-8. PubMed ID: 26597426
    [Abstract] [Full Text] [Related]

  • 12. Macrocyclic peptidomimetics with antimicrobial activity: synthesis, bioassay, and molecular modeling studies.
    Ibrahim MA, Panda SS, Oliferenko AA, Oliferenko PV, Girgis AS, Elagawany M, Küçükbay FZ, Panda CS, Pillai GG, Samir A, Tämm K, Hall CD, Katritzky AR.
    Org Biomol Chem; 2015 Sep 28; 13(36):9492-503. PubMed ID: 26256838
    [Abstract] [Full Text] [Related]

  • 13. Broad spectrum antibacterial and antifungal polymeric paint materials: synthesis, structure-activity relationship, and membrane-active mode of action.
    Hoque J, Akkapeddi P, Yadav V, Manjunath GB, Uppu DS, Konai MM, Yarlagadda V, Sanyal K, Haldar J.
    ACS Appl Mater Interfaces; 2015 Jan 28; 7(3):1804-15. PubMed ID: 25541751
    [Abstract] [Full Text] [Related]

  • 14. Ovotransferrin Antibacterial Peptide Coupling Mesoporous Silica Nanoparticle as an Effective Antibiotic Delivery System for Treating Bacterial Infection In Vivo.
    Ma B, Chen Y, Hu G, Zeng Q, Lv X, Oh DH, Fu X, Jin Y.
    ACS Biomater Sci Eng; 2022 Jan 10; 8(1):109-118. PubMed ID: 34936344
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization and biological studies of sulfonamide Schiff's bases and some of their metal derivatives.
    Chohan ZH, Shad HA, Supuran CT.
    J Enzyme Inhib Med Chem; 2012 Feb 10; 27(1):58-68. PubMed ID: 21534864
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance.
    Kiani MH, Imran M, Raza A, Shahnaz G.
    Daru; 2020 Jun 10; 28(1):319-332. PubMed ID: 32193748
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic resistance in bacteria and its future for novel antibiotic development.
    Yoneyama H, Katsumata R.
    Biosci Biotechnol Biochem; 2006 May 10; 70(5):1060-75. PubMed ID: 16717405
    [Abstract] [Full Text] [Related]

  • 19. [Drug delivery system for infectious diseases].
    Maesaki S, Kohno S.
    Nihon Rinsho; 1998 Mar 10; 56(3):752-61. PubMed ID: 9549369
    [Abstract] [Full Text] [Related]

  • 20. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
    Seefeld MA, Miller WH, Newlander KA, Burgess WJ, DeWolf WE, Elkins PA, Head MS, Jakas DR, Janson CA, Keller PM, Manley PJ, Moore TD, Payne DJ, Pearson S, Polizzi BJ, Qiu X, Rittenhouse SF, Uzinskas IN, Wallis NG, Huffman WF.
    J Med Chem; 2003 Apr 24; 46(9):1627-35. PubMed ID: 12699381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.